Detalhe da pesquisa
1.
Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.
Ann Hematol
; 103(2): 443-448, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38072850
2.
ABCG2 in Acute Myeloid Leukemia: Old and New Perspectives.
Int J Mol Sci
; 24(8)2023 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37108308
3.
Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
Br J Haematol
; 189(5): 888-903, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32017044
4.
Correction to: Correlation between IPSETt risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.
Ann Hematol
; 103(2): 449, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38157002
5.
JAK2 V617F-mutated polycythemia vera developing in a patient with a 20-year-long chronic myeloid leukemia at the time of first molecular response.
Ann Hematol
; 102(5): 1279-1280, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36947213
6.
Optimal timing of molecular monitoring after tyrosine kinase inhibitor discontinuation in chronic myeloid leukemia.
Eur J Haematol
; 110(3): 330-331, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36458956
7.
ABCG2 and CD200 define patients at high risk of relapse in ELN favorable subgroup of AML.
Eur J Haematol
; 99(3): 269-274, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28618016
8.
ABCG2, Cytogenetics, and Age Predict Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Complete Remission.
Biol Blood Marrow Transplant
; 22(9): 1621-1626, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27178373
9.
Haploidentical transplant after failure of a first allogeneic transplant: A long and winding road.
Eur J Haematol
; 106(6): 871-872, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33650204
10.
ABCG2 overexpression in patients with acute myeloid leukemia: Impact on stem cell transplantation outcome.
Am J Hematol
; 90(9): 784-9, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26059733
11.
ATP-Binding Cassette Subfamily G Member 2 in Acute Myeloid Leukemia: A New Molecular Target?
Biomedicines
; 12(1)2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38255216
12.
BAALC overexpression retains its negative prognostic role across all cytogenetic risk groups in acute myeloid leukemia patients.
Am J Hematol
; 88(10): 848-52, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23760853
13.
Checkpoint Inhibitors in Acute Myeloid Leukemia.
Biomedicines
; 11(6)2023 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37371818
14.
B-cell prolymphocytic leukemia with P53 abnormalities successfully treated with bendamustine and rituximab: a report of three cases.
Transl Cancer Res
; 12(7): 1873-1882, 2023 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37588745
15.
BCR::ABL1 levels at first month after TKI discontinuation predict subsequent maintenance of treatment-free remission: A study from the "GRUPPO TRIVENETO LMC".
Cancer Med
; 12(3): 3180-3184, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208021
16.
ABCG2 overexpression and deoxyadenosine analogue activity in acute myeloid leukemia.
Cancer
; 123(24): 4934-4935, 2017 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29053186
17.
Histone post-translational modifications associated to BAALC expression in leukemic cells.
Biochem Biophys Res Commun
; 417(2): 721-5, 2012 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22197554
18.
Donor compatibility and performance status affect outcome of allogeneic haematopoietic stem cell transplant in patients with relapsed or refractory acute myeloid leukaemia.
Ann Hematol
; 91(12): 1937-43, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22893485
19.
Impact of fludarabine-based induction therapy on outcome of FLT3-/NPM1+ cytogenetically normal acute myeloid leukemia.
Am J Hematol
; 92(4): E45-E47, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28076884
20.
Present and Future Role of Immune Targets in Acute Myeloid Leukemia.
Cancers (Basel)
; 15(1)2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36612249